NOVEL COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS

A corrector agent capable of stabilizing a newly synthesized cystic fibrosis transmembrane conductance regulator (CFTR) protein, useful in the treatment of cystic fibrosis. Un agente corrector capaz de estabilizar una proteína reguladora de la conductancia transmembrana en la fibrosis quística (CFTR...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Brian S. BROWN, Nicolas DESROY, Sachin V. PATEL, Douglas CYR, Xueqing WANG, Koen Karel JANSEN, Jianguo JI, Adeline Marie Elise PALISSE, Jean-michel LEFRANCOIS, Gert Jules Hector DE WILDE, Mathieu Rafaël PIZZONERO, Rhalid AKKARI, Steven Emiel VAN DER PLAS, Philip R. KYM, Luke Jonathan ALVEY, Chris TSE, Pieter Isabelle Roger CLAES, Anurupa SHRESTHA, Elsa DE LEMOS, Gregory A. GFESSER, Romain Luc Marie GOSMINI, Xavier Marie BOCK, Katja E. CONRATH, Christel Jeanne Marie MENET, Oscar MAMMOLITI, Marlon D. COWART, Nuria Merayo MERAYO, Christopher Gaëtan HOUSSEMAN, Elizabeth C. SWIFT, Gregory John Robert NEWSOME, Béranger DUTHION
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!